Moderator:
Kelly Tickle, MSN, APN, PPCNP-BC
Pediatric Nurse Practitioner, Children’s Healthcare of Atlanta
Speaker:
Glaivy Batsuli, MD
Assistant Professor of Pediatrics, Emory University,
Dept. of Pediatrics Pediatric Hematologist
Div. of Pediatric Hematology and Oncology
Aflac Cancer & Blood Disorders Center/Children's Healthcare of Atlanta
After completing this activity, the participant should be better able to:
- Review the current treatment strategies for the management of inhibitors in patients with hemophilia A.
- Describe the prophylactic use of non-factor therapy in a population of pediatric patients with hemophilia A with inhibitors on immune tolerance induction therapy.
- Review the current understanding and remaining challenges in defining tolerance in hemophilia A management.